In May 2026, CITEST Diagnostics Inc. launched the Multi-Drug Rapid Test Panel (Urine), a convenient, self-testing solution built for quick, qualitative drug screening in human urine samples. Engineered with rapid chromatographic immunoassay technology and monoclonal antibodies, the test panel selectively detects elevated levels of multiple drugs and their metabolites at specified cut-off concentrations, delivering preliminary results that support fast, on-the-spot screening without requiring complex laboratory infrastructure.

Designed for user-friendly self-testing, the Multi-Drug Rapid Test Panel stands out with practical, customer-centric advantages: it offers a wide detection panel that simultaneously screens for multiple drugs and their metabolites in human urine with high specificity, enabling comprehensive screening in a single test. It supports customizable configurations, allowing tailored drug combinations to meet diverse market and customer demands. With no instruments required, the test features simple, intuitive operation ideal for self-use, and delivers fast, reliable results that can be read within just 5 minutes, making the entire screening process efficient and convenient.

Built for consistent, accessible performance, the test panel operates on the principle of rapid chromatographic immunoassay, requiring only a urine specimen and no specialized training to administer. The product is identified by catalog number RTMDUX4CIH (X: 2-20), with each kit containing 1 test unit (1T) for single-use screening. Importantly, the test is intended solely for self-testing purposes and is not approved for in vitro diagnostic use, with all preliminary results requiring confirmation by gold-standard methods such as GC/MS or LC/MS for formal diagnostic purposes.

The Multi-Drug Rapid Test Panel fills a critical gap in accessible drug screening, delivering high-specificity, rapid results without the complexity of laboratory testing, making preliminary drug screening accessible to individuals and communities seeking reliable, at-home testing solutions. By merging comprehensive screening capability, customizable flexibility, and user-friendly design, the new test panel reinforces CITEST’s position as a trusted provider of accessible diagnostic tools, prioritizing convenience and reliability in everyday health screening.